What is the most recent earnings date for VYGR stock?
VOYAGER THERAPEUTICS INC (VYGR) last reported earnings on 3/9/2026.
NASDAQ:VYGR • US92915B1061
Past quarterly earnings results for VOYAGER THERAPEUTICS INC (VYGR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.46 | -0.52 | 11.66% | 22.03% | 15.336M | 10.698M | 43.35% | 144.28% |
| Q3 2025 | -0.47 | -0.53 | 11.46% | -193.75% | 13.365M | 8.015M | 66.75% | -45.73% |
| Q2 2025 | -0.57 | -0.54 | -6.33% | -216.67% | 5.2M | 10.106M | -48.55% | -82.42% |
| Q1 2025 | -0.53 | -0.46 | -15.73% | -165.00% | 6.473M | 13.827M | -53.19% | -66.83% |
| Q4 2024 | -0.59 | -0.37 | -57.86% | -147.20% | 6.278M | 16.909M | -62.87% | -93.03% |
| Q3 2024 | -0.16 | -0.46 | 65.43% | 72.88% | 24.629M | 12.129M | 103.06% | 433.79% |
| Q2 2024 | -0.18 | -0.42 | 56.91% | 64.71% | 29.578M | 9.65M | 206.51% | 509.48% |
| Q1 2024 | -0.20 | -0.45 | 55.44% | -106.80% | 19.516M | 9.603M | 103.23% | -87.03% |
| Q4 2023 | 1.25 | -0.29 | 524.68% | 304.92% | 90.061M | 21.048M | 327.88% | 6,104.07% |
| Q3 2023 | -0.59 | -0.59 | 0.49% | -231.11% | 4.614M | 2.966M | 55.56% | -88.77% |
| Q2 2023 | -0.51 | -0.58 | 12.06% | -2.00% | 4.853M | 1.632M | 197.37% | 593.29% |
| Q1 2023 | 2.94 | 0.79 | 273.52% | 625.00% | 150.48M | 41.82M | 259.83% | 21,397.14% |
| Q4 2022 | -0.61 | -0.56 | -9.30% | -506.67% | -1.5M | 4.271M | -135.12% | -105.34% |
| Q3 2022 | 0.45 | -0.32 | 239.11% | 167.16% | 41.1M | 9.604M | 327.95% | 2,640.00% |
| Q2 2022 | -0.50 | -0.32 | -54.39% | 37.50% | 700K | 13.041M | -94.63% | -50.00% |
| Q1 2022 | -0.56 | -0.35 | -59.46% | 3.45% | 700K | 14.705M | -95.24% | -89.23% |
| Q4 2021 | 0.15 | -0.32 | 146.44% | 134.88% | 28.1M | 14.837M | 89.39% | 332.31% |
| Q3 2021 | -0.67 | -0.74 | 9.71% | -129.52% | 1.5M | 2.186M | -31.38% | -98.73% |
| Q2 2021 | -0.80 | -0.73 | -10.08% | -247.83% | 1.4M | 4.867M | -71.23% | -95.12% |
| Q1 2021 | -0.58 | -0.67 | 13.32% | 12.12% | 6.5M | 5.523M | 17.69% | -64.09% |
| Q4 2020 | -0.43 | -0.58 | 25.40% | - | 6.5M | 13.584M | -52.15% | - |
| Q3 2020 | 2.27 | -0.20 | 1,263.66% | - | 117.8M | 38.082M | 209.33% | - |
| Q2 2020 | -0.23 | -0.73 | 68.54% | - | 28.7M | 15.836M | 81.23% | - |
| Q1 2020 | -0.66 | -0.81 | 18.21% | - | 18.1M | 13.817M | 31.00% | - |
Notes
VOYAGER THERAPEUTICS INC (VYGR) last reported earnings on 3/9/2026.
VOYAGER THERAPEUTICS INC (VYGR) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, VOYAGER THERAPEUTICS INC (VYGR) has beaten EPS estimates in 2 out of 4 releases.